Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

CytoSorb Blood Purification Results in Statistically Significant Reductions in Multiple Organ Failure and DysfunctionPRINCETON, N.J., Jan. 17, 2024 -- CytoSorbents Corporation , a leader in the...

Related Keywords

Hungary ,Canada ,Budapest ,United States ,Daniel Wendt ,Kathleen Bloch ,Adam Soltesz ,Cytosorbents Corporation ,Vascular Center At Semmelweis University ,European Union ,National Institutes Of Health ,Facebook ,National Heart ,Us Department Of Health ,Blood Institute ,Us Army ,Human Services ,Material Command ,Twitter ,Health Canada ,European Society Of Cardiology ,Us Air ,Bus Company Contact ,Cytosorb Blood Purification Results ,Statistically Significant Reductions ,Multiple Organ Failure ,Sorbents Corporation ,European Society ,Vascular Center ,Semmelweis University ,Vasoactive Inotropic Scores ,Vasoplegic Syndrome ,Vice President Medical ,Use Authorization ,Device Designations ,Timely Antithrombotic Removal Ticagrelor ,National Institutes ,Operations Command ,Air Force Material Command ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Markets ,